Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Annette M Chang

Showing results (21-30 of 23) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 23 results.
Diabetes, Obesity & Metabolism|August 4, 2016
Lipid changes during basal insulin peglispro, insulin glargine, or NPH treatment in six IMAGINE trialsHenry Ginsberg, Bertrand Cariou, Trevor Orchard, et al.
Plos One|September 17, 2014
Islet autoimmunity identifies a unique pattern of impaired pancreatic beta-cell function, markedly reduced pancreatic beta cell mass and insulin resistance in clinically diagnosed type 2 diabetesAngela Subauste, Roberto Gianani, Annette M Chang, et al.
Journal of Investigative Medicine : the Official Publication of the American Federation for Clinical Research|November 24, 2017
Cytokeratin-18 and enhanced liver fibrosis scores in type 1 and type 2 diabetes and effects of two different insulinsArun Sanyal, Kenneth Cusi, Mark L Hartman, et al.
Pageof 3

Showing results (21-30 of 23) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 23 results.
Diabetes, Obesity & Metabolism|August 4, 2016
Lipid changes during basal insulin peglispro, insulin glargine, or NPH treatment in six IMAGINE trialsHenry Ginsberg, Bertrand Cariou, Trevor Orchard, et al.
Plos One|September 17, 2014
Islet autoimmunity identifies a unique pattern of impaired pancreatic beta-cell function, markedly reduced pancreatic beta cell mass and insulin resistance in clinically diagnosed type 2 diabetesAngela Subauste, Roberto Gianani, Annette M Chang, et al.
Journal of Investigative Medicine : the Official Publication of the American Federation for Clinical Research|November 24, 2017
Cytokeratin-18 and enhanced liver fibrosis scores in type 1 and type 2 diabetes and effects of two different insulinsArun Sanyal, Kenneth Cusi, Mark L Hartman, et al.
Pageof 3